摘要
目的:探讨手术在局限期小细胞肺癌(SCLC)治疗中的作用,并分析影响其预后的因素,为小细胞肺癌手术治疗提供科学依据。方法:对本院1985年1月~2005年12月间收治的,且组织学病理以及影像学明确诊断为局限期小细胞肺癌的70例手术患者进行生存时间的分析,经Kaplan-Meier生存分析、Cox回归分析等方法,探讨影响小细胞肺癌手术疗效的相关预后因素。结果:本组SCLC手术患者Ⅰ期、Ⅱ期以及Ⅲ期的5年生存率分别为63.8%、40.1%、33.2%。Cox单因素以及多因素分析表明:TNM分期、是否行化疗、手术方式和KPS评分是影响SCLC患者手术预后的独立危险因素。结论:以手术为主的治疗能使局限期SCLC患者受益,且TNM分期、是否行化疗、患者KPS评分是影响其预后的独立危险因素。
Objective:To explore the potential role of the surgical treatment in limited small cell lung cancer(SCLC) and analyze the factors affecting the prognosis.Methods:From January 1985 to December 2005,the survival rate of 70 in-patients with limited SCLC confirmed by histological pathology and imaging were analyzed.Furthermore,the related prognostic factors of patients underwent surgery were investigated by Kaplan-Meier estimator and Cox regression analysis.Results:The five-year survival rates of patients with stage Ⅰ,Ⅱ,Ⅲ SCLC were 63.8%,40.1% and 33.2%,respectively.The Cox regression analysis indicated that TNM stage,application of platinum-based chemotherapy,operative manner and KPS scores were independent prognostic factors for SCLC patients after surgery.Conclusion:Patients with limited SCLC may benefit from the comprehensive treatment based on surgery.TNM stage,application of platinum-based chemotherapy,operative manner and KPS scores were independent prognostic factors for SCLC patients after surgery.
出处
《南京医科大学学报(自然科学版)》
CAS
CSCD
北大核心
2011年第7期1032-1035,共4页
Journal of Nanjing Medical University(Natural Sciences)
基金
南京医科大学科技发展基金面上项目(2010NJ-MU017)
关键词
小细胞肺癌
手术
预后
small cell lung cancer
surgical treatment
prognosis